---
$id: https://graph.org.ai/products/commodity/51294411
$type: Product
source: UNSPSC
code: "51294411"
title: "Trazitiline"
class: "51294400"
classTitle: "Antidepressant piperazines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trazitiline

**UNSPSC Code**: 51294411
**Class**: [Antidepressant piperazines](Antidepressant piperazines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7I6MS3VHQE, chemically known as 1-(9,10-ethanoanthracen-9(10h)-yl)-4-methylpiperazine but generally known as trazitiline, which bears US NIH Compound Identifier 3084449. European Medicines Agency schedules Trazitiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11222MIG. The term TRAZITILINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). TRAZITILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trazitiline under HS 29335995 and SITC 51576. As of Q4 2014, TRAZITILINE remains the US FDA Preferred Term for this commodity. Trazitiline bears US NLM identifiers UMLS ID C1883383 and NCI Concept Code C66617. SMILES: N1(C23CCC(c4c2cccc4)c2c3cccc2)CCN(CC1)C.

